Autors:

CiteWeb id: 19880000145

CiteWeb score: 3169

DOI: 10.1056/NEJM198805193182007

IN this seminar we review recent studies suggesting that the central pathologic features of diabetic complications are caused by the hyperglycemia-accelerated formation of nonenzymatic advanced glycosylation end products in tissue. We will emphasize new research findings with important clinical implications, since older information is available in previously published reviews.1 , 2 Other biochemical mechanisms by which hyperglycemia may contribute to the development of diabetic complications are not discussed here, since they are comprehensively reviewed elsewhere.3 4 5 6 7 8 Differences between Early and Advanced Glycosylation Products The central pathophysiologic features of diabetic vascular complications are an abnormal leakage of proteins from the circulation and a progressive . . .

The publication "Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications" is placed in the Top 10000 of the best publications in CiteWeb. Also in the category Medicine it is included to the Top 1000. Additionally, the publicaiton "Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications" is placed in the Top 1000 among other scientific works published in 1988.
Links to full text of the publication: